Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest

This trial tested whether giving the immunotherapy drug pembrolizumab before and after local ablation (using heat or radiation to destroy tumors) could improve outcomes for 30 people with early-stage liver cancer. The goal was to see if the drug could shrink tumors enough to make…